Explore how shifting sector dynamics, breakthrough medical innovations and the pharmaceutical patent cliff are reshaping healthcare investing. Andy Acker and Seth Meyer discuss the key opportunities active investors may be overlooking.
Your
Goals
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
Explore how shifting sector dynamics, breakthrough medical innovations and the pharmaceutical patent cliff are reshaping healthcare investing. Andy Acker and Seth Meyer discuss the key opportunities active investors may be overlooking.
What rising open model adoption could mean for infrastructure spending, hyperscalers, and AI labs.
Exploring the differences within the riskier segment of high yield bonds.
How advisors can help manage the common cognitive biases that may cloud investors’ decision-making during election season.
Jessica Leoncini, Alex Veroude and Tom Ross examine how AI, quantitative analysis, market dispersion and public-private asset convergence are expanding fixed income opportunities and enhancing the value of active security selection.
Why the return of corporate pricing power provides further evidence that this inflationary regime change is already under way.
Heightened IRS scrutiny around Grantor Retained Annuity Trusts has made meticulous execution of this estate-planning strategy more critical than ever.
Why investors should view El Niño and La Niña as part of a wider climate system, with compounding effects on markets, sectors and portfolio risk.
Join Richard Bernstein and Seth Meyer as they discuss deglobalisation, persistent inflation, equity market leadership and emerging investment opportunities.
Looking at the potential significance of an 8% yield threshold for investors in high yield bonds.
Jessica Leoncini, Dan Siluk and John Lloyd discuss the return of income in fixed income, duration risk, liquidity trade-offs, and where active investors may find value.